ATTORNEY PROFILES

Robert Roseman

Robert Roseman

Founding Partner

P: 215-496-0300
E: rroseman@srkattorneys.com

Bar Admissions

Pennsylvania, 1983
New York, 1989
U.S. Supreme Court
U.S. Court of Appeals 3rd Circuit, 1983
U.S. Court of Appeals 7th Circuit
U.S. District Court Eastern District of Pennsylvania, 1983
U.S. District Court Central District of Illinois
U.S. Federal Courts, 1983
U.S. Court of Federal Claims

Education

J.D. Temple University School of Law
Philadelphia, Pennsylvania, 1982

B.S. State University of New York
Brockport, New York, 1978

Honors: Cum Laude
Major: Political Science

Professional Associations and Memberships

Philadelphia Bar Association Member
Pennsylvania Bar Association, 1983 – Present
Member, Civil Judicial Procedures Committee
New York State Bar Association
American Bar Association Member
Council of Institutional Investors
International Corporate Governance Network

ROBERT M. ROSEMAN

Mr. Roseman, founding partner, chairs the Firm’s international and domestic securities practice group.  Mr. Roseman focuses his practice on investor protection issues, including the enforcement of the federal securities laws and state laws involving fiduciary duties of directors and officers, and under the laws in the various jurisdictions in Europe where group actions can be brought.  An important component of his practice involves protecting U.S. and European investors in European proceedings.  In that role, he works with U.S. and European institutional investors on investor protection and corporate governance matters.

The most notable example of Mr. Roseman’s role as Co­Lead Counsel is in the Converium/SCOR action, where he prosecuted the first U.S. securities class action settled on two continents (for a collective $145 million).  The European portion of this settlement was adjudicated before the Court of Appeal in Amsterdam using the then recently enacted Dutch Act on the Collective Settlements of Mass Damage Claims.  Importantly, Mr. Roseman’s international expertise helped secure a landmark decision from the Dutch Court of Appeal in this case that will make it easier in the future for U.S. and European investors to claim monies recovered from actions brought in the Netherlands.

Mr. Roseman represented European institutions and was co­lead counsel in the landmark In re Parmalat Securities Litigation action, the largest fraud in European corporate history that is frequently referred to as Europe’s Enron, which settled for $96.5 million.  There, Mr. Roseman devised a unique legal theory against the bankrupt Parmalat that used Italian bankruptcy law to secure funds not normally available to investors. He also extracted corporate governance endorsements from defendants other than the issuer ­a first in a U.S,­based investor action.

Among other notable cases, Mr. Roseman represented Brussels­based KBC Asset Management in In re Royal Dutch/Shell Securities Litigation and Brussels­based Fortis Investments in In re Chicago Bridge and Iron Securities Litigation. He represented the Northern Ireland Local Government Officers’ Superannuation Committee, a UK institution, which was one of the lead plaintiffs in the massive U.S. investor action involving Lehman Brothers and was co­lead counsel In re Atheros Communications Shareholder Litigation, in which he obtained a preliminary injunction of a merger where inadequate information about the transaction had been disclosed to shareholders.

Mr. Roseman has been at the vanguard of using securities class actions and derivative suits to implement corporate governance changes at U.S. and European companies to help them operate more effectively and reduce the likelihood that wrongdoing will occur in the future.  He litigated as lead counsel against the directors of Abbott Labs (involving off label marketing of Depakote) in which the company agreed for a four year period to implement cutting-edge, bespoke reforms addressing allegations of illegal conduct which are designed to prevent it from occurring in the future, including an incentive compensation clawback requirement which goes beyond the requirements in the Dodd-Frank Act.  As co-lead counsel Mr. Roseman litigated against the directors of Archer Daniels Midland Company in which the corporation agreed to implement significant reforms which, at that time, were “state of the art” corporate governance measures designed to strengthen the independence of the board of directors.  Mr. Roseman also litigated against the directors of Abbott Laboratories (Abbott I) and settled the case for numerous corporate governance changes governing the way in which the board of directors addresses regulatory matters. The Seventh Circuit’s landmark decision in this case was named second among the top ten securities law decisions of 2003 by the American Bar Association’s Securities Litigation Journal.

Mr. Roseman has written extensively on securities and investor protection issues, including Global Markets, Global Fraud: What We Can Learn from ‘Europe’s Enron’, Investment and Pensions Europe (May 2006 supp.); Cost­Effective Monitoring of Corporate Fraud: Reducing the Time Necessary to Stay Informed, Investment and Pensions Europe (June 2006 supp.); and, A Trans­Atlantic Trend, Professional Investor (May 2005).  He also appeared in a roundtable discussion in Global Pensions (October 2006 supp.).

Mr. Roseman has been a frequent speaker at numerous U.S. and international conferences on the issues of investor protection through litigation and engagement and the importance of using corporate governance measures as part of settlements to ensure that Board of Directors act in the best interest of the Company and its shareholders.  In addition to speaking at numerous conferences in the U.S., Mr. Roseman appeared as an invited speaker at institutional investor conferences held in London, Paris, Munich, Milan, Barcelona, Brussels, Paris, Frankfurt and Dublin and the Annual Conference of the International Corporate Governance Network in Amsterdam and in Paris.

Robert Roseman

Founding Partner
P: 215-496-0300
E: rroseman@srkattorneys.com

ROBERT M. ROSEMAN

Mr. Roseman, founding partner, chairs the Firm’s international and domestic securities practice group.  Mr. Roseman focuses his practice on investor protection issues, including the enforcement of the federal securities laws and state laws involving fiduciary duties of directors and officers, and under the laws in the various jurisdictions in Europe where group actions can be brought.  An important component of his practice involves protecting U.S. and European investors in European proceedings.  In that role, he works with U.S. and European institutional investors on investor protection and corporate governance matters.

The most notable example of Mr. Roseman’s role as Co­Lead Counsel is in the Converium/SCOR action, where he prosecuted the first U.S. securities class action settled on two continents (for a collective $145 million).  The European portion of this settlement was adjudicated before the Court of Appeal in Amsterdam using the then recently enacted Dutch Act on the Collective Settlements of Mass Damage Claims.  Importantly, Mr. Roseman’s international expertise helped secure a landmark decision from the Dutch Court of Appeal in this case that will make it easier in the future for U.S. and European investors to claim monies recovered from actions brought in the Netherlands.

Learn More

Mr. Roseman represented European institutions and was co­lead counsel in the landmark In re Parmalat Securities Litigation action, the largest fraud in European corporate history that is frequently referred to as Europe’s Enron, which settled for $96.5 million.  There, Mr. Roseman devised a unique legal theory against the bankrupt Parmalat that used Italian bankruptcy law to secure funds not normally available to investors. He also extracted corporate governance endorsements from defendants other than the issuer ­a first in a U.S,­based investor action.

Among other notable cases, Mr. Roseman represented Brussels­based KBC Asset Management in In re Royal Dutch/Shell Securities Litigation and Brussels­based Fortis Investments in In re Chicago Bridge and Iron Securities Litigation. He represented the Northern Ireland Local Government Officers’ Superannuation Committee, a UK institution, which was one of the lead plaintiffs in the massive U.S. investor action involving Lehman Brothers and was co­lead counsel In re Atheros Communications Shareholder Litigation, in which he obtained a preliminary injunction of a merger where inadequate information about the transaction had been disclosed to shareholders.

Mr. Roseman has been at the vanguard of using securities class actions and derivative suits to implement corporate governance changes at U.S. and European companies to help them operate more effectively and reduce the likelihood that wrongdoing will occur in the future.  He litigated as lead counsel against the directors of Abbott Labs (involving off label marketing of Depakote) in which the company agreed for a four year period to implement cutting-edge, bespoke reforms addressing allegations of illegal conduct which are designed to prevent it from occurring in the future, including an incentive compensation clawback requirement which goes beyond the requirements in the Dodd-Frank Act.  As co-lead counsel Mr. Roseman litigated against the directors of Archer Daniels Midland Company in which the corporation agreed to implement significant reforms which, at that time, were “state of the art” corporate governance measures designed to strengthen the independence of the board of directors.  Mr. Roseman also litigated against the directors of Abbott Laboratories (Abbott I) and settled the case for numerous corporate governance changes governing the way in which the board of directors addresses regulatory matters. The Seventh Circuit’s landmark decision in this case was named second among the top ten securities law decisions of 2003 by the American Bar Association’s Securities Litigation Journal.

Mr. Roseman has written extensively on securities and investor protection issues, including Global Markets, Global Fraud: What We Can Learn from ‘Europe’s Enron’, Investment and Pensions Europe (May 2006 supp.); Cost­Effective Monitoring of Corporate Fraud: Reducing the Time Necessary to Stay Informed, Investment and Pensions Europe (June 2006 supp.); and, A Trans­Atlantic Trend, Professional Investor (May 2005).  He also appeared in a roundtable discussion in Global Pensions (October 2006 supp.).

Mr. Roseman has been a frequent speaker at numerous U.S. and international conferences on the issues of investor protection through litigation and engagement and the importance of using corporate governance measures as part of settlements to ensure that Board of Directors act in the best interest of the Company and its shareholders.  In addition to speaking at numerous conferences in the U.S., Mr. Roseman appeared as an invited speaker at institutional investor conferences held in London, Paris, Munich, Milan, Barcelona, Brussels, Paris, Frankfurt and Dublin and the Annual Conference of the International Corporate Governance Network in Amsterdam and in Paris.

Robert Roseman

Founding Partner
P: 215-496-0300
E: rroseman@srkattorneys.com

ROBERT M. ROSEMAN

Mr. Roseman, founding partner, chairs the Firm’s international and domestic securities practice group.  Mr. Roseman focuses his practice on investor protection issues, including the enforcement of the federal securities laws and state laws involving fiduciary duties of directors and officers, and under the laws in the various jurisdictions in Europe where group actions can be brought.  An important component of his practice involves protecting U.S. and European investors in European proceedings.  In that role, he works with U.S. and European institutional investors on investor protection and corporate governance matters.

The most notable example of Mr. Roseman’s role as Co­Lead Counsel is in the Converium/SCOR action, where he prosecuted the first U.S. securities class action settled on two continents (for a collective $145 million).  The European portion of this settlement was adjudicated before the Court of Appeal in Amsterdam using the then recently enacted Dutch Act on the Collective Settlements of Mass Damage Claims.  Importantly, Mr. Roseman’s international expertise helped secure a landmark decision from the Dutch Court of Appeal in this case that will make it easier in the future for U.S. and European investors to claim monies recovered from actions brought in the Netherlands.

Learn More

Mr. Roseman represented European institutions and was co­lead counsel in the landmark In re Parmalat Securities Litigation action, the largest fraud in European corporate history that is frequently referred to as Europe’s Enron, which settled for $96.5 million.  There, Mr. Roseman devised a unique legal theory against the bankrupt Parmalat that used Italian bankruptcy law to secure funds not normally available to investors. He also extracted corporate governance endorsements from defendants other than the issuer ­a first in a U.S,­based investor action.

Among other notable cases, Mr. Roseman represented Brussels­based KBC Asset Management in In re Royal Dutch/Shell Securities Litigation and Brussels­based Fortis Investments in In re Chicago Bridge and Iron Securities Litigation. He represented the Northern Ireland Local Government Officers’ Superannuation Committee, a UK institution, which was one of the lead plaintiffs in the massive U.S. investor action involving Lehman Brothers and was co­lead counsel In re Atheros Communications Shareholder Litigation, in which he obtained a preliminary injunction of a merger where inadequate information about the transaction had been disclosed to shareholders.

Mr. Roseman has been at the vanguard of using securities class actions and derivative suits to implement corporate governance changes at U.S. and European companies to help them operate more effectively and reduce the likelihood that wrongdoing will occur in the future.  He litigated as lead counsel against the directors of Abbott Labs (involving off label marketing of Depakote) in which the company agreed for a four year period to implement cutting-edge, bespoke reforms addressing allegations of illegal conduct which are designed to prevent it from occurring in the future, including an incentive compensation clawback requirement which goes beyond the requirements in the Dodd-Frank Act.  As co-lead counsel Mr. Roseman litigated against the directors of Archer Daniels Midland Company in which the corporation agreed to implement significant reforms which, at that time, were “state of the art” corporate governance measures designed to strengthen the independence of the board of directors.  Mr. Roseman also litigated against the directors of Abbott Laboratories (Abbott I) and settled the case for numerous corporate governance changes governing the way in which the board of directors addresses regulatory matters. The Seventh Circuit’s landmark decision in this case was named second among the top ten securities law decisions of 2003 by the American Bar Association’s Securities Litigation Journal.

Mr. Roseman has written extensively on securities and investor protection issues, including Global Markets, Global Fraud: What We Can Learn from ‘Europe’s Enron’, Investment and Pensions Europe (May 2006 supp.); Cost­Effective Monitoring of Corporate Fraud: Reducing the Time Necessary to Stay Informed, Investment and Pensions Europe (June 2006 supp.); and, A Trans­Atlantic Trend, Professional Investor (May 2005).  He also appeared in a roundtable discussion in Global Pensions (October 2006 supp.).

Mr. Roseman has been a frequent speaker at numerous U.S. and international conferences on the issues of investor protection through litigation and engagement and the importance of using corporate governance measures as part of settlements to ensure that Board of Directors act in the best interest of the Company and its shareholders.  In addition to speaking at numerous conferences in the U.S., Mr. Roseman appeared as an invited speaker at institutional investor conferences held in London, Paris, Munich, Milan, Barcelona, Brussels, Paris, Frankfurt and Dublin and the Annual Conference of the International Corporate Governance Network in Amsterdam and in Paris.

Bar Admissions

Pennsylvania, 1983
New York, 1989
U.S. Supreme Court
U.S. Court of Appeals 3rd Circuit, 1983
U.S. Court of Appeals 7th Circuit
U.S. District Court Eastern District of Pennsylvania, 1983
U.S. District Court Central District of Illinois
U.S. Federal Courts, 1983
U.S. Court of Federal Claims

Education

J.D. Temple University School of Law
Philadelphia, Pennsylvania, 1982

B.S. State University of New York
Brockport, New York, 1978

Honors: Cum Laude
Major: Political Science

Professional Associations and Memberships

Philadelphia Bar Association Member
Pennsylvania Bar Association, 1983 – Present
Member, Civil Judicial Procedures Committee
New York State Bar Association
American Bar Association Member
Council of Institutional Investors
International Corporate Governance Network